SCN 1A /Na V 1.1 channelopathies: Mechanisms in expression systems, animal models, and human iPSC models
Massimo Mantegazza (IPMC), Vania Broccoli

TL;DR
This review discusses the mechanisms of SCN1A/NaV1.1 channel mutations causing epilepsy and migraine, highlighting insights from expression systems, animal models, and human iPSC models, and emphasizing the complexity of their pathological effects.
Contribution
It provides a comprehensive overview of experimental approaches and findings on SCN1A/NaV1.1 mutations, comparing their advantages, limitations, and insights into disease mechanisms.
Findings
Loss-of-function of NaV1.1 causes hypoexcitability in GABAergic neurons.
Some FHM mutations involve gain-of-function effects.
Complex pathophysiological responses and technical issues complicate understanding.
Abstract
Pathogenic SCN1A/NaV1.1 mutations cause well defined epilepsies, including Genetic Epilepsy with Febrile Seizures Plus (GEFS+) and the severe epileptic encephalopathy Dravet syndrome. In addition, they cause a severe form of migraine with aura, Familial Hemiplegic Migraine. Moreover, SCN1A/NaV1.1 variants have been inferred as risk factors in other types of epilepsy. We review here the advancements obtained studying pathological mechanisms of SCN1A/NaV1.1 mutations with experimental systems. We present results gained with in vitro expression systems, gene targeted animal models and the iPSC technology, highlighting advantages, limits and pitfalls for each of these systems. Overall, the results obtained in the last two decades confirm that the initial pathological mechanism of epileptogenic SCN1A/NaV1.1 mutations is loss-of-function of NaV1.1 leading to hypoexcitability of at least…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
